Depression in neuropsychiatry diseases;Depresszió neuropszichiátriai betegségekben

Ideggyogyaszati Szemle

Volumn 65, Issue 1-2, 2012, Pages 6-15

  Hidasi, Zoltán ^a   Salacz, Pál ^a   Csibri, Éva ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Dementia; Depression; Epilepsy; Neurobiology; Neuropsychiatry; Parkinson's disease; Poststroke depression

Indexed keywords

NEUROHORMONE; NEUROTRANSMITTER;

CEREBROVASCULAR DISEASE; COMORBIDITY; DEMENTIA; DEPRESSION; EPILEPSY; EVALUATION; HUMAN; NEUROANATOMY; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROTROPISM; PARKINSON DISEASE; PATHOGENESIS; REVIEW;

CEREBROVASCULAR DISORDERS; COMORBIDITY; DEMENTIA; DEPRESSION; EPILEPSY; HUMANS; PARKINSON DISEASE; RISK FACTORS;

EID: 84857723263     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (Revised 4th ed.). Washington DC, 2011.
2. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894-902.
3. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34:13-25. (Pubitemid 34270695)
4. Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron 1998;21:467-76. (Pubitemid 28475499)
5. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 2001;24:429-58. (Pubitemid 32695235)
6. Ahima RS, Osei SY. Molecular regulation of eating behavior: new insights and prospects for therapeutic strategies. Trends Mol Med 2001;7:205-13. (Pubitemid 32822892)
7. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci 1999;877:412-38. (Pubitemid 29351870)
8. de Olmos JS, Heimer L. The concepts of the ventral striatopallidal system and extended amygdala. Ann NY Acad Sci 1999;877:1-32. (Pubitemid 29351848)
9. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb J M, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651-60. (Pubitemid 40320700)
10. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008;33:368-77. (Pubitemid 350243349)
11. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-13. (Pubitemid 26144221)
12. Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998;9:2023-8. (Pubitemid 28300560)
13. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-43. (Pubitemid 29270138)
14. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003;160:1516-8. (Pubitemid 41070930)
15. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002;22:3251-61. (Pubitemid 35379212)
16. Holsboer F. Corticotropin-releasing hormone modulators and depression. Curr Opin Investig Drugs 2003;4:46-50. (Pubitemid 36253678)
17. McEwen BS. Allostasis and allostatic load:implications for neuropsychopharmacology. Neuropsychopharmacology 2000;22:108-24.
18. Fuchs E, Gould E. Mini-review: in vivo neurogenesis in the adult brain:regulation and functional implications. Eur J Neurosci 2000;12:2211-4. (Pubitemid 30497018)
19. Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002;51:273-9. (Pubitemid 34214992)
20. Lai T, Payne ME, Byrum CE, Steffens DC, Krishnan KR. Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry 2000;48:971-5.
21. Koenigs M, Grafman J. The functional neuroanatomy of depression:distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009;201:239-43.
22. Baxter LR, Jr., Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243-50. (Pubitemid 19078261)
23. Richelson E. Biological basis of depression and therapeutic relevance. J Clin Psychiatry 1991;52:4-10.
24. Schildkraut JJ. The catecholamine hypothesis of affective disorders:a review of supporting evidence. Am J Psychiatry 1965;122:509-22.
25. Shiah IS, Yatham LN. GABA function in mood disorders: an update and critical review. Life Sci 1998;63:1289-303. (Pubitemid 29369125)
26. Karege F, Vaudan G, Schwald M, Perroud N, La HR. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005;136:29-37. (Pubitemid 40704606)
27. Smith MA, Makino S, Kvetnansky R, Post RM. Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci 1995;771:234-9. (Pubitemid 26077410)
28. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539-47.
29. Duman RS, Monteggia LM:A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59:1116-27.
30. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression:when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56. (Pubitemid 350295688)
31. Dunn AJ, Swiergiel AH, deBeaurepaireR. Cytokines as mediators of depression:what can we learn from animal studies? Neurosci Biobehav Rev 2005;29:891-909. (Pubitemid 40755469)
32. Levinson DF. The genetics of depressions review. Biol Psychiatry 2006;60:84-92.
33. Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poeggeler B, Cardinali DP. Pathophysiology of depression:role of sleep and the melatonergic system. Psychiatry Res 2009;165:201-14.
34. Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, et al. Psychiatric morbidity in dementia with Lewy bodies:a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry 1999;156:1039-45. (Pubitemid 29302797)
35. Ballard C, Neill D, O'Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 2000;59:97-106. (Pubitemid 30317426)
36. Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry 2003;54:353-62. (Pubitemid 37270616)
37. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry 2003;160:857-66. (Pubitemid 41079569)
38. Paterniti S, Verdier-Taillefer MH, Dufouil C, Alperovitch A. Depressive symptoms and cognitive decline in elderly people. Longitudinal study. Br J Psychiatry 2002;181:406-10 (Pubitemid 35333108)
39. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry 2004;75:1662-6. (Pubitemid 39611460)
40. Craig D, Mirakhur A, Hart DJ, Mcllroy SP, Passmore AP. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Am J Geriatr Psychiatry 2005;13:460-8.
41. Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, et al. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. NeuroBiol Aging 2009;30:1406-12.
42. McCulley MC, Day IN, Holmes C. Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2004;124B:50-3. (Pubitemid 38031592)
43. Tanzi RE, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001;32:181-4. (Pubitemid 33030187)
44. Weinshenker D. Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr Alzheimer Res 2008;5:342-5. (Pubitemid 351840281)
45. Mossello E, Boncinelli M, Caleri V, Cavallini MC, Palermo E, Di BM, et al. Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease? Dement Geriatr Cogn Disord 2008;25:372-9. (Pubitemid 351562960)
46. Suranyi-Cadotte BE, Gauthier S, Lafaille F, DeFlores S, Dam TV, Nair NP, Quirion R. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia. Life Sci 1985;37:2305-11. (Pubitemid 16169771)
47. Meynen G, Unmehopa UA, Hofman MA, Swaab DF, Hoogendijk WJ. Relation between corticotropin-releasing hormone neuron number in the hypothalamic paraventricular nucleus and depressive state in Alzheimer's disease. Neuroendocrinology 2007;85:37-44. (Pubitemid 46550024)
48. Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P. NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons. Proc Natl Acad Sci U.S.A 2008;105:13139-44.
49. Appel J, Potter E, Shen Q, Pantol G, Greig MT, Loewenstein D, Duara R. A comparative analysis of structural brain MRI in the diagnosis of Alzheimer's disease. Behav Neurol 2009;21:13-9.
50. Wenk GL. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003;64 Suppl 9:7-10. (Pubitemid 37040372)
51. Leonard BE. Evidence for a biochemical lesion in depression. J Clin Psychiatry 2000;61 Suppl 6:12-7. (Pubitemid 30217406)
52. Richartz-Salzburger E, Batra A, Stransky E, Laske C, Kohler N, Bartels M, et al. Altered lymphocyte distribution in Alzheimer's disease. J Psychiatr Res 2007;41:174-8. (Pubitemid 44708214)
53. Wuwongse S, Chang RC, Law AC. The putative neurodegenerative links between depression and Alzheimer's disease. Prog Neuro Biol 2010;91:362-75.
54. Korczyn AD, Halperin I. Depression and dementia. J Neurol Sci 2009;283:139-42.
55. Brun A. Pathology and pathophysiology of cerebrovascular dementia:pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994;5:145-7. (Pubitemid 24151536)
56. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501. (Pubitemid 27147602)
57. Park JH, Lee SB, Lee TJ, Lee DY, Jhoo JH, Youn JC et al. Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease. Dement Geriatr Cogn Disord 2007;23:67-73. (Pubitemid 46105696)
58. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008;23:183-9. (Pubitemid 351311545)
59. Cummings JL. Depression and Parkinson's disease:a review. Am J Psychiatry 1992;149:443-54.
60. Nilsson FM, Kessing LV, Bolwig TG. Increased risk of developing Parkinson's disease for patients with major affective disorder:a register study. Acta Psychiatr Scand 2001;104:380-6. (Pubitemid 34280555)
61. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's diseases quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381-9. (Pubitemid 16108903)
62. Arabia G, Grossardt BR, Geda YE, Carlin JM, Bower JH, Ahlskog JE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry 2007;64:1385-92. (Pubitemid 350223556)
63. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del TK. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121-34. (Pubitemid 39362633)
64. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991;50:743-55.
65. Brown AS, Gershon S. Dopamine and depression. J Neural Transm Gen Sect 1993;91:75-109. (Pubitemid 23131299)
66. Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, et al. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dement Geriatr Cogn Disord 2008;26:330-8.
67. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64. (Pubitemid 20222152)
68. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997;8:1057-61. (Pubitemid 27152174)
69. Lisanby SH, McDonald WM, Massey EW, Doraiswamy PM, Rozear M, Boyko OB, et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm Suppl 1993;40:13-21. (Pubitemid 24005553)
70. Eastwood MR, Rifat SL, Nobbs H, Ruderman J. Mood disorder following cerebrovascular accident. Br J Psychiatry 1989;154:195-200. (Pubitemid 19050159)
71. Robinson RG. Poststroke depression:prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54:376-87. (Pubitemid 37267864)
72. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM. Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry 1995;166:320-7.
73. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of poststroke-depression: a double-blind study. Lancet 1984;1:297-300. (Pubitemid 14185332)
74. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993;24:976-82. (Pubitemid 23201453)
75. Robinson RG, Bolduc PL, Price TR. Two-year longitudinal study of poststroke mood disorders:diagnosis and outcome at one and two years. Stroke 1987;18:837-43. (Pubitemid 17135384)
76. Mayberg HS, Robinson RG, Wong DF, Parikh R, Bolduc P, Starkstein SE, et al. PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 1988;145:937-43.
77. Robinson RG, Bloom FE. Pharmacological treatment following experimental cerebral infarction:implications for understanding psychological symptoms of human stroke. Biol Psychiatry 1977;12:669-80. (Pubitemid 8225387)
78. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V. Temporal profile of serum anti-inflammatory and proinflammatory interleukins in acute ischemic stroke patients. Neurol Sci 2001;22:289-96. (Pubitemid 34071562)
79. Ramasubbu R, Tobias R, Bech-Hansen NT. Extended evaluation of serotonin transporter gene functional polymorphisms in subjects with poststroke- depression. Can J Psychiatry 2008;53:197-201. (Pubitemid 351469379)
80. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol 1981;9:447-53. (Pubitemid 11120581)
81. Provinciali L, Coccia M. Post-stroke and vascular depression: a critical review. Neurol Sci 2002;22:417-28. (Pubitemid 34436804)
82. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood changes in stroke patients: relationship to lesion location. Compr Psychiatry 1983;24:555-66. (Pubitemid 14207739)
83. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, Sharpe M. Depression after stroke and lesion locations systematic review. Lancet 2000;356:122-6. (Pubitemid 30438513)
84. Singh A, Herrmann N, Black SE. The importance of lesion location in poststroke depression: a critical review. Can J Psychiatry 1998;43:921-7. (Pubitemid 29173301)
85. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry 1999;45:187-92. (Pubitemid 29079449)
86. Cummings, JL, Mega JL. Disturbances of mood and affectxerebrovascular disease. Cummings, J. L. and Mega J.L. 206. 2003. New York, NY: Oxford University Press; 2003. p. 206.
87. Vataja R, Leppavuori A, Pohjasvaara T, Mantyla R, Aronen HJ, Salonen O, Kaste M, Erkinjuntti T. Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci 2004;16:156-62. (Pubitemid 38560898)
88. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-22. (Pubitemid 128719702)
89. Tang WK, Chen YK, Lu JY, Chu WC, Mok VC, Ungvari GS, et al. White matter hyperintensities in poststroke-depression: a case control study. J Neurol Neurosurg Psychiatry 2010;81:1312-5.
90. Santos M, Kovari E, Gold G, Bozikas VP, Hof PR, Bouras C, Giannakopoulos P. The neuroanatomical model of post-stroke-depression:towards a change of focus? J Neurol Sci 2009;283:158-62.
91. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 1998;158:1133-8. (Pubitemid 28242319)
92. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke:thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 2001;32:1979-83. (Pubitemid 32878509)
93. Koenig W. Inflammation and coronary heart disease: an overview. Cardiol Rev 2001;9:31-5. (Pubitemid 32060596)
94. Kanner AM. Depression and epilepsys review of multiple facets of their close relation. Neurol Clin 2009;27:865-80.
95. Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology 2002;58:S27-S39. (Pubitemid 34428637)
96. Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry 2000;8:8-17. (Pubitemid 30246612)
97. Forsgren L, Nystrom L. An incident case-referent study of epileptic seizures in adults. Epilepsy Res 1990;6:66-81. (Pubitemid 20172108)
98. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000;47:246-9. (Pubitemid 30078574)
99. Shamim S, Hasler G, Liew C, Sato S, Theodore WH. Temporal lobe epilepsy, depression, and hippocampal volume. Epilepsia 2009;50:1067-71.
100. Elst LT, Groffmann M, Ebert D, Schulze-Bonhage A. Amygdala volume loss in patients with dysphoric disorder of epilepsy. Epilepsy Behav 2009;16:105-12.
101. Gilliam FG, Maton BM, Martin RC, Sawrie SM, Faught RE, Hugg JW, et al. Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 2007;68:364-8. (Pubitemid 46184212)
102. Bromfield EB, Altshuler L, Leiderman DB, Balish M, Ketter TA, Devinsky O, et al. Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol 1992;49:617-23.
103. Hajszan T, Maclusky NJ. Neurologic links between epilepsy and depression in women:is hippocampal neuroplasticity the key? Neurology 2006;66:S13-S22. (Pubitemid 43739804)
104. Jobe PC, Dailey JW, Wernicke JF. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 1999;13:317-56.
105. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004;62:586-90. (Pubitemid 38252800)
106. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol 2001;58:1081-6. (Pubitemid 32660771)
107. Then BF, Kumpfel T, Trenkwalder C, Rupprecht R, Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 1999;53:772-7. (Pubitemid 29448298)
108. Silver JM, McAllister TW, Arciniegas DB. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry 2009;166:653-61.
109. Gesztelyi G. Primary headache and depression. Orv Hetil 2004;145:2419-24.
110. Ruoff GE. Depression in the patient with chronic pain. J Fam Pract 1996;43:S25-S33.
111. Must A, Horváth Sz, Janka Z. Affective and cognitive decision makin gin major depression: influence of the prefrontal cortex, serotonin transporter genotype and personality traits. Ideggyogy Sz 2008;61(5-6):175-9.
112. Szily E, Kéri Sz. Emotion-related brain regions. Ideggyogy Sz 2008;61(3-4):77-86.